StockData
Humana Inc logo

Humana Inc (HUM) stock

HUMNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3051% above fair value
$450.00+6.32 (+1.42%)

Close on Nov 13, 2026Market cap $54.04BP/E 43.6Yield 0.79%

Humana operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Humana's operating cash flow for the twelve months ending Sep 30, 2026 was $3.73B, up 82.4% year over year. For fiscal 2025 it was $921.00M, down 68.9% from the year before. Over ten years it grew 0.6% a year on average. The highest annual figure on record is $5.64B in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$921.00M-68.9%
FY2024Dec 31, 2024$2.97B-25.5%
FY2023Dec 31, 2023$3.98B-13.2%
FY2022Dec 31, 2022$4.59B+102.8%
FY2021Dec 31, 2021$2.26B-59.9%
FY2020Dec 31, 2020$5.64B+6.7%
FY2019Dec 31, 2019$5.28B+143.2%
FY2018Dec 31, 2018$2.17B-46.4%
FY2017Dec 31, 2017$4.05B+109.2%
FY2016Dec 31, 2016$1.94B+123.0%
FY2015Dec 31, 2015$868.00M-46.4%
FY2014Dec 31, 2014$1.62B-5.7%
FY2013Dec 31, 2013$1.72B-10.8%
FY2012Dec 31, 2012$1.92B-7.5%
FY2011Dec 31, 2011$2.08B-7.3%
FY2010Dec 31, 2010$2.24B+57.7%
FY2009Dec 31, 2009$1.42B+44.8%
FY2008Dec 31, 2008$982.31M-19.8%
FY2007Dec 31, 2007$1.22B–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.16B+122.8%
Q2 FY2026Jun 30, 2026$1.97B+54.7%
Q1 FY2026Mar 31, 2026$1.25B+278.9%
Q4 FY2025Dec 31, 2025-$1.65B–
Q3 FY2025Sep 30, 2025$971.00M-47.7%
Q2 FY2025Jun 30, 2025$1.27B+4.8%
Q1 FY2025Mar 31, 2025$331.00M-21.7%
Q4 FY2024Dec 31, 2024-$528.00M–
Q3 FY2024Sep 30, 2024$1.86B+48.4%
Q2 FY2024Jun 30, 2024$1.21B-61.8%
Q1 FY2024Mar 31, 2024$423.00M-93.7%
Q4 FY2023Dec 31, 2023-$7.13B–
Q3 FY2023Sep 30, 2023$1.25B-85.2%
Q2 FY2023Jun 30, 2023$3.18B+231.2%
Q1 FY2023Mar 31, 2023$6.69B+2114.2%
Q4 FY2022Dec 31, 2022-$5.13B–
Q3 FY2022Sep 30, 2022$8.45B+198.2%
Q2 FY2022Jun 30, 2022$959.00M+166.4%
Q1 FY2022Mar 31, 2022$302.00M–
Q4 FY2021Dec 31, 2021-$96.00M-133.9%
Q3 FY2021Sep 30, 2021$2.84B+56.2%
Q2 FY2021Jun 30, 2021$360.00M-88.3%
Q1 FY2021Mar 31, 2021-$837.00M-276.6%
Q4 FY2020Dec 31, 2020$283.00M-44.7%
Q3 FY2020Sep 30, 2020$1.82B-25.7%
Q2 FY2020Jun 30, 2020$3.07B+113.9%
Q1 FY2020Mar 31, 2020$474.00M-47.1%
Q4 FY2019Dec 31, 2019$512.00M–
Q3 FY2019Sep 30, 2019$2.44B–
Q2 FY2019Jun 30, 2019$1.43B–
Q1 FY2019Mar 31, 2019$896.00M-75.7%
Q4 FY2018Dec 31, 2018-$333.00M–
Q3 FY2018Sep 30, 2018-$1.06B-136.8%
Q2 FY2018Jun 30, 2018-$125.00M–
Q1 FY2018Mar 31, 2018$3.69B-12.3%
Q4 FY2017Dec 31, 2017-$2.91B–
Q3 FY2017Sep 30, 2017$2.86B–
Q2 FY2017Jun 30, 2017-$106.00M–
Q1 FY2017Mar 31, 2017$4.21B–
Q4 FY2016Dec 31, 2016-$2.77B–

More Humana figures

See a number that looks wrong?